Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine

THOUSAND OAKS, Calif., Sept. 20, 2020 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that updated data from the full Phase 1 cohort of the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 129 patients across

New COVID-19 test could give results in under 1 hour

Researchers say they’ve developed a low-cost swab test that can diagnose COVID-19 infections in about 45 minutes. The CRISPR-based test—which uses gene-targeting technology and requires no specialized equipment—could help relieve testing backlogs in the United